This inventor holds 1 USPTO granted patent. Top assignee: Bracco Imaging S.p.a.. Active years: 2008.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2008
Title: Giancarlo Morelli: Innovator in Therapeutic Peptides
Introduction
Giancarlo Morelli is a notable inventor based in Milan, Italy. He has made significant contributions to the field of therapeutic agents through his innovative work on cyclic and branched peptides. His research focuses on the preparation and application of these peptides as diagnostic and therapeutic agents.
Latest Patents
Morelli holds a patent titled "Preparation and use of cyclic and branched peptides and their labelled derivatives as therapeutic agents, cholecystokinin agonists or antagonists, and diagnostic agents to identify and locate tumours." This patent describes the preparation of cyclic and branched peptides of general formula (I) and their conjugated derivatives labelled with a paramagnetic or radioactive metal. The compounds developed in this invention are utilized as diagnostic agents to identify and locate primary tumours and their metastases, which over-express type A and/or B cholecystokinin receptors. Additionally, they serve as therapeutic agents and cholecystokinin agonists or antagonists.
Career Highlights
Giancarlo Morelli is associated with Bracco Imaging S.p.A., a company known for its advancements in medical imaging. His work has contributed to the development of innovative solutions in the healthcare sector, particularly in cancer diagnostics and treatment.
Collaborations
Morelli has collaborated with notable colleagues, including Michele Saviano and Diego Tesauro. These partnerships have enhanced the research and development of therapeutic peptides, leading to advancements in medical applications.
Conclusion
Giancarlo Morelli's contributions to the field of therapeutic peptides highlight his role as an innovator in medical science. His patent work and collaborations reflect a commitment to improving diagnostic and therapeutic methods for cancer treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile